NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Kala Pharmaceuticals (KALA) Technical (Analysis) Reports Kala Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Kala Pharmaceuticals (KALA)

Technical Analysis Report for USA stock KALA Kala Pharmaceuticals. Dated: 27 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock KALA Kala Pharmaceuticals then click here. or read Experts views on Kala Pharmaceuticals or Forecast & share price targets of Kala Pharmaceuticals

Kala Pharmaceuticals Opened at 0.80 and Closed at: 0.81, which is -1.23% of previous session's close. It moved within a range of 0.80 and 0.85
The session was a Bullish session with an average volume of 32200, which is -89.75% of previous session's volumes.

• The stock has fallen, and its mid term trend is also negative and in a downtrend.

Support for tomorrow is 0.81 and resistance for tomorrow is 0.86
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 0.79, 0.77 resistance for tomorrow's hourly charts is 0.84, 0.87

10 Day SMA for Kala Pharmaceuticals (KALA) is 0.86 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Kala Pharmaceuticals (KALA) is 0.82 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Kala Pharmaceuticals (KALA) is 1.21 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 1.34 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Kala Pharmaceuticals is 0.93 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Kala Pharmaceuticals is at 0.82 and 200 DMA is at 0.93, while 50 DMA and 100 DMA are at 1.21 and 1.34 respectively

Kala Pharmaceuticals (KALA) moving average of 20 SMA is at 0.82 and 20 EMA is at 0.86

Kala Pharmaceuticals (KALA) moving average of 50 SMA is at 1.21 and 50 EMA is at 1.09

Kala Pharmaceuticals (KALA) moving average of 100 SMA is at 1.34 and 100 EMA is at 1.22

Kala Pharmaceuticals (KALA) moving average of 200 SMA is at 0.93 and 200 EMA is at 1.84

Kala Pharmaceuticals has performed better than Johnson Johnson in short term. Holding Kala Pharmaceuticals could be a better choice for now!

Humana Inc has performed better than Kala Pharmaceuticals in short term. You could have earned much better returns by investing in Humana Inc, about 1.33% more returns!

Kala Pharmaceuticals has performed better than Boston Scientific in short term. Holding Kala Pharmaceuticals could be a better choice for now!

Kala Pharmaceuticals has performed better than Abbott Laboratories in short term. Holding Kala Pharmaceuticals could be a better choice for now!

Rhythm Pharmaceuticals has performed better than Kala Pharmaceuticals in short term. You could have earned much better returns by investing in Rhythm Pharmaceuticals, about 6.8% more returns!

Kala Pharmaceuticals has performed better than Pavmed Inc in short term. Holding Kala Pharmaceuticals could be a better choice for now!

Kala Pharmaceuticals has performed better than Organogenesis Holdings in short term. Holding Kala Pharmaceuticals could be a better choice for now!

Opko Health has performed better than Kala Pharmaceuticals in short term. You could have earned much better returns by investing in Opko Health, about 7.06% more returns!

Medicinova Inc has performed better than Kala Pharmaceuticals in short term. You could have earned much better returns by investing in Medicinova Inc, about 0.19% more returns!

Meiragtx Holdings has performed better than Kala Pharmaceuticals in short term. You could have earned much better returns by investing in Meiragtx Holdings, about 13.35% more returns!

Moleculin Biotech has performed better than Kala Pharmaceuticals in short term. You could have earned much better returns by investing in Moleculin Biotech, about 65.92% more returns!

Kala Pharmaceuticals has performed better than Livanova Plc in short term. Holding Kala Pharmaceuticals could be a better choice for now!

Atyr Pharma has performed better than Kala Pharmaceuticals in short term. You could have earned much better returns by investing in Atyr Pharma, about 86.56% more returns!

Kura Oncology has performed better than Kala Pharmaceuticals in short term. You could have earned much better returns by investing in Kura Oncology, about 39.7% more returns!

Helius Medical has performed better than Kala Pharmaceuticals in short term. You could have earned much better returns by investing in Helius Medical, about 40.69% more returns!

Kala Pharmaceuticals has performed better than Gossamer Bio in short term. Holding Kala Pharmaceuticals could be a better choice for now!

Fulgent Genetics has performed better than Kala Pharmaceuticals in short term. You could have earned much better returns by investing in Fulgent Genetics, about 13.96% more returns!

Kala Pharmaceuticals has performed better than Dare Bioscience in short term. Holding Kala Pharmaceuticals could be a better choice for now!

Alnylam Pharmaceuticals has performed better than Kala Pharmaceuticals in short term. You could have earned much better returns by investing in Alnylam Pharmaceuticals, about 8.51% more returns!

Kala Pharmaceuticals Technical analysis of indicators

Price action analysis of Kala Pharmaceuticals (KALA) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

ADX buy sell signal for Kala Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Kala Pharmaceuticals in short term but the buy signal is initial and weak.

Kala Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Kala Pharmaceuticals in short term

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Kala Pharmaceuticals is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 0.86 and Kala Pharmaceuticals KALA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Kala Pharmaceuticals KALA stock. Volume based technical analysis of Kala Pharmaceuticals KALA stock is negative.

Kala Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock KALA Kala Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And KALA Experts View which covers a lot of information including buying and selling signals

KALA future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Kala Pharmaceuticals or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet